Oliver Simić

1.0k total citations
16 papers, 727 citations indexed

About

Oliver Simić is a scholar working on Organic Chemistry, Biotechnology and Surgery. According to data from OpenAlex, Oliver Simić has authored 16 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 4 papers in Biotechnology and 3 papers in Surgery. Recurrent topics in Oliver Simić's work include Catalytic C–H Functionalization Methods (6 papers), Synthesis and Catalytic Reactions (6 papers) and Marine Sponges and Natural Products (4 papers). Oliver Simić is often cited by papers focused on Catalytic C–H Functionalization Methods (6 papers), Synthesis and Catalytic Reactions (6 papers) and Marine Sponges and Natural Products (4 papers). Oliver Simić collaborates with scholars based in Switzerland, Germany and United Kingdom. Oliver Simić's co-authors include Carsten Bolm, Alessandra Antonello, Martin D. Smith, Steven F. Oliver, Steven V. Ley, Klemens Högenauer, Marc Martín, Christian P. R. Hackenberger, Ed Cleator and Hiroaki Okamura and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Oliver Simić

16 papers receiving 712 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oliver Simić Switzerland 14 534 196 98 87 80 16 727
Andrew Madin United Kingdom 18 815 1.5× 435 2.2× 193 2.0× 47 0.5× 33 0.4× 35 1.1k
Michael C. Matelich United States 7 335 0.6× 211 1.1× 23 0.2× 104 1.2× 32 0.4× 9 606
Matthew G. LaPorte United States 17 429 0.8× 237 1.2× 28 0.3× 37 0.4× 27 0.3× 37 711
Cédrickx Godbout Canada 14 568 1.1× 176 0.9× 34 0.3× 169 1.9× 15 0.2× 17 643
Baudouin Gerard United States 14 480 0.9× 617 3.1× 26 0.3× 38 0.4× 15 0.2× 20 970
Klemens Högenauer Austria 10 263 0.5× 231 1.2× 18 0.2× 83 1.0× 66 0.8× 15 510
John J. Gaudino United States 15 501 0.9× 323 1.6× 46 0.5× 36 0.4× 11 0.1× 19 642
Jean‐Christophe Carry France 8 344 0.6× 258 1.3× 34 0.3× 18 0.2× 31 0.4× 11 572
Anne Birmingham United States 8 169 0.3× 317 1.6× 42 0.4× 29 0.3× 125 1.6× 8 579
Bernard Côté Canada 19 923 1.7× 292 1.5× 49 0.5× 309 3.6× 48 0.6× 26 1.3k

Countries citing papers authored by Oliver Simić

Since Specialization
Citations

This map shows the geographic impact of Oliver Simić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Simić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Simić more than expected).

Fields of papers citing papers by Oliver Simić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Simić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Simić. The network helps show where Oliver Simić may publish in the future.

Co-authorship network of co-authors of Oliver Simić

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Simić. A scholar is included among the top collaborators of Oliver Simić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Simić. Oliver Simić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Schlapbach, Achim, Láśzló Révész, Carole Pissot‐Soldermann, et al.. (2018). N-aryl-piperidine-4-carboxamides as a novel class of potent inhibitors of MALT1 proteolytic activity. Bioorganic & Medicinal Chemistry Letters. 28(12). 2153–2158. 18 indexed citations
2.
Simić, Oliver, Philip R. Skaanderup, Kenji Namoto, et al.. (2016). Trypsin inhibitors for the treatment of pancreatitis. Bioorganic & Medicinal Chemistry Letters. 26(17). 4340–4344. 14 indexed citations
3.
Boettcher, Andreas, Rainer Kneuer, Farid Sari‐Sarraf, et al.. (2013). In Vivo Imaging with Fluorescent Smart Probes to Assess Treatment Strategies for Acute Pancreatitis. PLoS ONE. 8(2). e55959–e55959. 6 indexed citations
4.
Boettcher, Andreas, Rainer Kneuer, Farid Sari‐Sarraf, et al.. (2013). Correction: In Vivo Imaging with Fluorescent Smart Probes to Assess Treatment Strategies for Acute Pancreatitis. PLoS ONE. 8(10). 4 indexed citations
5.
Schiering, Nikolaus, A. D’Arcy, Frédéric Villard, et al.. (2011). A macrocyclic HCV NS3/4A protease inhibitor interacts with protease and helicase residues in the complex with its full-length target. Proceedings of the National Academy of Sciences. 108(52). 21052–21056. 47 indexed citations
6.
Andrews, Stephen P., Matthew Ball, Ed Cleator, et al.. (2007). Total Synthesis of Five Thapsigargins: Guaianolide Natural Products Exhibiting Sub‐Nanomolar SERCA Inhibition. Chemistry - A European Journal. 13(20). 5688–5712. 74 indexed citations
7.
Ostermann, Nils, Jörg Eder, Ulf Eidhoff, et al.. (2005). Crystal Structure of Human BACE2 in Complex with a Hydroxyethylamine Transition-state Inhibitor. Journal of Molecular Biology. 355(2). 249–261. 36 indexed citations
8.
Bolm, Carsten, et al.. (2005). Ethylene‐Bridged Bissulfoximines in Copper‐Catalyzed Enantioselective Hetero‐Diels‐‐Alder Reactions. Advanced Synthesis & Catalysis. 347(11-13). 1696–1700. 14 indexed citations
9.
Ley, Steven V., Alessandra Antonello, Emily P. Balskus, et al.. (2004). Synthesis of the thapsigargins. Proceedings of the National Academy of Sciences. 101(33). 12073–12078. 65 indexed citations
10.
Oliver, Steven F., Klemens Högenauer, Oliver Simić, et al.. (2003). A Route to the Thapsigargins from (S)‐Carvone Providing a Substrate‐Controlled Total Synthesis of Trilobolide, Nortrilobolide, and Thapsivillosin F. Angewandte Chemie International Edition. 42(48). 5996–6000. 100 indexed citations
11.
Bolm, Carsten, et al.. (2003). A new class of C1-symmetric monosulfoximine ligands for enantioselective hetero Diels–Alder reactions. Chemical Communications. 2826–2827. 50 indexed citations
12.
Bolm, Carsten, et al.. (2003). C2-Symmetric Bissulfoximines as Ligands in Copper-Catalyzed Enantioselective Diels−Alder Reactions. Organic Letters. 5(4). 427–429. 61 indexed citations
13.
Oliver, Steven F., Klemens Högenauer, Oliver Simić, et al.. (2003). A Route to the Thapsigargins from (S)‐Carvone Providing a Substrate‐Controlled Total Synthesis of Trilobolide, Nortrilobolide, and Thapsivillosin F. Angewandte Chemie. 115(48). 6178–6182. 14 indexed citations
14.
Bolm, Carsten, et al.. (2002). A Mild Synthetic Procedure for the Preparation of N-Alkylated Sulfoximines. Synthesis. 2002(7). 879–887. 49 indexed citations
15.
Bolm, Carsten & Oliver Simić. (2001). Highly Enantioselective Hetero-Diels−Alder Reactions Catalyzed by aC2-Symmetric Bis(sulfoximine) Copper(II) Complex. Journal of the American Chemical Society. 123(16). 3830–3831. 145 indexed citations
16.
Bolm, Carsten, Oliver Simić, & Marc Martín. (2001). C2-Symmetric Bissulfoximines in Palladium-catalyzed Allylic Alkylations. Synlett. 2001(12). 1878–1880. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026